Recent publications:
Fuller HR and Morris GE (2012) “Quantitative proteomics
using iTRAQ labeling
and mass spectrometry” in Integrative Proteomics, InTech,
ISBN: 978-953-51-0070-6.
Humphrey EH, Fuller HR, Morris GE
(2011) Current research on SMN protein and treatment strategies for SMA. Neuromuscular
Disorders. 22(2):193-7.
Comley LH†, Fuller HR†, Wishart TM, Mutsaers
CA, Thomson D, Wright AK, Ribchester RR, Morris
GE, Parson SH, Horsburgh K, Gillingwater
TH (2011) ApoE isoform-specific regulation of
regeneration in the peripheral nervous system. Hum Mol Genet.
2011(12):2406-2421. † Denotes equal
author contribution.
Fuller HR, Man NT, Lam Le T, Shamanin VA,
Androphy EJ and Morris GE (2010) Valproate and
bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin
in SMA cells. J Proteome Res. 9 (8): 4228–4233.
Fuller HR, Man NT, Lam le T, Thanh
le T, Keough RA, Asperger A, Gonda TJ, Morris GE
(2010) The SMN interactome includes Myb-binding
protein 1a. J Proteome Res. 9(1):556-63.
Walter MN, Wright KT, Fuller HR, Macneil
S, Johnson WE (2010) Mesenchymal stem
cell-conditioned medium accelerates skin wound healing: An in vitro study
of fibroblast and keratinocyte scratch assays.
Exp Cell Res. 316(7):1271-81.
Fuller HR, Marija B, Šimić Đurđica
S, Špeljko T, Morris GE, Šimić
G (2010) Treatment strategies for spinal muscular atrophy. Translational Neuroscience. 1(4):308-321.
Fuller HR and Morris GE (2010) SMN complexes in the
nucleus and cytoplasm as targets for SMA therapy: a proteomic study. Translational Neuroscience. 1(4): 261-267.
Fuller HR (2010) Immunoassay and mass spectrometry
studies of antigens in food. Basics, concepts and
methods. Lambert academic publishing ISBN: 978-3-8383-4385-3.